Costs, throughput time, and proportion of valid test results, a model-based analysis of liquid biopsies for stage IV non-small cell lung cancer.

被引：0
|
作者：
Koole, Simone N.
Schouten, Robert
Vessies, Daan
Schuurbiers, Milou
Bosch, Linda J. W.
van den Heuvel, Michel
van Harten, Wim
van den Broek, Daan
Monkhorst, Kim
Retel, Valesca P.
机构：
[1] Netherlands Canc Inst, Dept Hlth Econ, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Radboud Univ, Med Ctr, Nijmegen, Netherlands
[4] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
[5] RadboudUMC, Dept Thorac Oncol, Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18844
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18844
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Timing of immunotherapy in stage IV non-small cell lung cancer.
    Komiya, Takefumi
    Zhu, Junjia
    Takamori, Shinkichi
    Greenberg, Max
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Use of chemotherapy for patients with stage IV non-small cell lung cancer.
    Waqar, Sadaf Huma
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha
    Gao, Feng
    Robinson, Cliff Grant
    Puri, Varun
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Liquid biopsies for the front line therapy decision in non-small cell lung cancer.
    Brice, Kayla
    Raez, Luis E.
    Dumais, Katerine
    Wietecha, Delia
    Lopez-Cohen, Alejandro
    Izquierdo, Paola
    Drusbosky, Leylah
    Dada, Hiba I.
    Powery, Herman W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Stage IV non-small cell lung cancer.: Duration of chemotherapy for locally advanced non small cell lung cancers
    Vergnenegre, A.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (05) : S72 - S77
  • [5] Stage IV non-small cell lung cancer. What is the best treatment for relapse?
    Sculier, J. -P
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (05) : S78 - S83
  • [6] Depression and EGFR mutation status in stage IV non-small cell lung cancer.
    Pirl, W. F.
    Greer, J.
    Bemis, H.
    Heist, R. S.
    Gallagher, E.
    Sequist, L. V.
    Engelman, J. A.
    Traeger, L.
    Lennes, I. T.
    Temel, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Integrating blood based liquid biopsies with TNM stage improves survival prediction model for non-small cell lung cancer
    Schmalz, Lauren
    Urtis, Cetin
    Liu, Liang
    Forbes, Elizabeth
    Hsu, Fang-Chi
    Steuerwald, Nury
    de Hoyos, Alberto
    Lycan, Thomas
    Ruiz, Jimmy
    Petty, William
    Zhang, Wei
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Therapy of non-small cell lung cancer in stage IV
    Deppermann, Karl-Matthias
    Huber, Rudolf M.
    Laack, Eckart
    Reck, Martin
    Serke, Monika
    von Pawel, Joachim
    ONKOLOGIE, 2006, 29 : 15 - 19
  • [9] Surgery for stage IV non-small cell lung cancer?
    Puig, Carlos A.
    Wigle, Dennis
    JOURNAL OF THORACIC DISEASE, 2020, 12 (04) : 1612 - 1614
  • [10] Province-wide analysis of patient reported outcomes for stage IV non-small cell lung cancer.
    Tjong, Michael Chandra
    Doherty, Mark
    Tan, Hendrick
    Chan, Wing
    Zhao, Haoyu
    Hallet, Julie
    Darling, Gail Elizabeth
    Kidane, Biniam
    Wright, Frances Catriona
    Mahar, Alyson
    Davis, Laura E.
    Delibasic, Victoria
    Parmar, Ambika
    Mittmann, Nicole
    Coburn, Natalie G.
    Louie, Alexander V.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345